SUBSCRIBE
SUBSCRIBE

bluebird bio

NEWS
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Job Trends
Cambridge’s bluebird bio Will Move to Huge Kendall Square Space Next Year
September 30, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Deals
Partnership and Acquisition Rumors in the CAR-T Cancer Space Finger Juno, Kite Pharma and bluebird bio
July 16, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Kite Pharma, bluebird bio Ink Deal to Zero In on HPV-Linked Cancer
June 22, 2015
 · 
4 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
bluebird bio Surges as Pioneering Sickle Cell Gene Therapy Working for 13-Year-Old French Boy
June 15, 2015
 · 
5 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Drug Development
bluebird bio Defies RAC Panel’s Recommendation, Will Proceed With Two Planned Trials
June 10, 2015
 · 
5 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Business
Celgene Will Focus On Anti-BCMA Drug, As It Returns CAR-T Pack to bluebird bio
June 4, 2015
 · 
4 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
bluebird bio Pads CAR T Arsenal With $131.5 Million Five Prime Pact
May 27, 2015
 · 
8 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Drug Development
Stock Soars as bluebird bio Gives Sneak Peek at Promising Sickle Cell Data
May 21, 2015
 · 
4 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Investors Rejoice as bluebird bio Plots Road to First-Ever U.S. Gene Therapy Approval
May 19, 2015
 · 
5 min read
Load More
AWARDS
  • 2022 Best Places to Work
JOBS
IN THE PRESS
bluebird bio Rebrands as Genetix Biotherapeutics, Returning to Its Foundational Roots
September 18, 2025
 · 
4 min read
bluebird bio Strengthens Leadership Team With New Appointments
July 2, 2025
 · 
3 min read
bluebird bio Announces Completion of Acquisition by Carlyle and SK Capital
June 2, 2025
 · 
6 min read
Carlyle and SK Capital Partners Announce Expiration of bluebird bio Tender Offer
May 30, 2025
 · 
7 min read
bluebird bio Reminds Stockholders to Act Now to Tender Shares for Acquisition by Carlyle and SK Capital
May 27, 2025
 · 
5 min read
Carlyle, SK Capital Partners and bluebird bio Provide Updated Tender Instructions
May 16, 2025
 · 
10 min read
Carlyle, SK Capital Partners and bluebird bio Amend Merger Agreement
May 14, 2025
 · 
6 min read
Important Information for bluebird bio Stockholders to Tender Shares for Acquisition by Carlyle and SK Capital
May 9, 2025
 · 
8 min read
Carlyle and SK Capital Receive All Required Regulatory Approvals to Complete the Acquisition of bluebird bio
May 6, 2025
 · 
11 min read
bluebird bio confirms that Ayrmid, Ltd. has not delivered a binding offer or obtained necessary financing despite extensive engagement
April 16, 2025
 · 
10 min read